Healthcare Industry News: cardiac monitor
News Release - February 10, 2011
U.S. Postal Inspection Service Awards AED Contract to Cardiac SciencePowerheart AEDs to be deployed nationwide
BOTHELL, Wash., Feb. 10, 2011 -- (Healthcare Sales & Marketing Network) -- Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has been awarded a contract to deploy Powerheart® AEDs at U.S. Postal Inspection Service sites across the nation. The U.S. Postal Inspection Service is the primary law enforcement arm of the United States Postal Service.
"We are proud to have been selected to protect the men and women of the Postal Inspection Service," said Dave Marver, Cardiac Science president and chief executive officer.
The Powerheart AED's RescueCoach™ user-paced voice prompts and CPR metronome guide rescuers confidently through a stressful rescue situation. The Powerheart AED G3 Plus delivers a shock automatically with no button to push and no human intervention. After the shock, the Powerheart AED instructs users how to perform high-quality CPR.
About Sudden Cardiac Arrest
Sudden cardiac arrest is a leading cause of death in North America, claiming more than 365,000 lives each year. It's estimated that more than 95 percent of cardiac arrest victims die before reaching the hospital. In cardiac arrest, the heart's electrical impulses fire irregularly and the heart cannot pump blood to the rest of the body. A defibrillator is the only effective therapy for sudden cardiac arrest. It provides a life-saving shock to effectively restart the heart's electrical impulses.
About Cardiac Science
Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, and YouTube at http://budurl.com/CSonYT.
For more information, contact (media) firstname.lastname@example.org +1.425.402.2092 | (investors) email@example.com | +91.80.2852.8088
Source: Cardiac Science
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.